This page shows all events ABCP (co-)organised and will be (co-)organising. Some events (co-)sponsored or supported by ABCP may also be included.
ABCP Virtual Seminar: The economic burden of COVID-19 in China
17 July @ 4:00 pm - 5:00 pm
The economic burden of COVID-19 in China
Dr Huajie (Lily) Jin (金桦杰博士), Senior Health Economist, King’s College London, UK
The talk will be delivered in English.
COVID-19 swept through China in 2019-2020, with over 83,000 confirmed cases reported by end of June 2020. In order to estimate the economic burden of COVID-19, we conducted a cost-of-illness study to estimate the healthcare and societal cost of COVID-19 in 31 provincial-level administrative regions in China. The main cost components included identification, diagnosis and treatment of COVID-19, compulsory quarantine and productivity losses for all affected residents in China during the study period. Input data were obtained from government reports, clinical guidelines, and other published literature. The total estimated healthcare and societal cost associated with the outbreak is 4.26 billion RMB (0.62 billion USD) and 2,647 billion RMB (383 billion USD), respectively. The main components of routine healthcare costs are inpatient care (41.0%) and medicines (30.9%). The main component of societal costs is productivity losses (99.8%). Hubei province incurred the highest healthcare cost (83.2%) whilst Guangdong province incurred the highest societal cost (14.6%).
Our study highlights a large economic burden of the recent COVID-19 outbreak in China. Evidence indicates that the control measures to prevent the spread of disease incurred substantial productivity costs amounting to over 2% of China’s annual GDP. The results of this study provide evidence to justify significant investment in prevention and control measures for future outbreaks.
Bio of Speaker
Dr Huajie Jin (Lily) has been a Senior Health Economist at King’s College London since 2013. Her role at King’s involves designing and conducting economic evaluations for or a range of policymakers and research organisations, including the NHS England, the National Institute for Health and Clinical Excellence (NICE), the National Institute for Health Research (NIHR), Medical Research Council (MRC), as well as voluntary sector and commercial organisations. Before joining King’s, Lily used to work on the National Institute for Health and Clinical Excellence (NICE) clinical guidelines for three years. Between Year 2011-2013, Lily was an honorary Research Fellow of Cardiff University, and an Honorary Research Associate of Swansea University.
Lily’s research focuses on health economic modelling, trial-based economic evaluations and systematic reviews. She has conducted economic evaluations for a range of healthcare interventions, including screening tests, diagnostic tests, drugs, radiotherapies, and service-level interventions, such as trainings for GPs, and liaison modes between primary care and secondary care services. Her work has been published in journals such as The Lancet Psychiatry, BMJ, PharmacoEconomics, PLOS One and JAMA Network Open. She was the principal health economist of three NICE clinical guidelines and three NICE Medtech innovation briefings (MIBs).
How to Participate
The seminar is open to all for free. The system allows up to 150 participants.
Please connect from your computer using the following link:
You can connect from web browser (which may require installing a web browser extension) or install the GoToMeeting app on your computer to join.
You can also dial in using your phone. (For supported devices, tap a one-touch number below to join instantly.)
United Kingdom: +44 330 221 0088 (One-touch dial:+443302210088,,577964533#)
Access Code: 577-964-533